Emergency contraception current value sales increased by 5% with value sales reaching EUR0.5 million in 2011. Emergency contraception posted a very strong performance after the economic crisis ended and consumer purchasing power rose for the first time after eleven consecutive quarters of decline: some women consider these products to be essential. Escapelle 1.5mg and Postinor-2 were the only two products available in 2011.
Euromonitor International's Emergency Contraception in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.Why buy this report?
* Get a detailed picture of the Emergency Contraception market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Click for Report details:Emergency Contraception in Estonia - Market Research Report